VCM
AMPH icon

Versant Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Versant Capital Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.4K Hold
218
– – ﹤0.01% 2453
2026
Q1 		$4.27K Sell
218
-144
-40% -$3.52K ﹤0.01% 2424
2025
Q4 		$9.69K Buy
362
+71
+24% +$1.83K ﹤0.01% 2009
2025
Q3 		$7.75K Sell
291
-333
-53% -$8.6K ﹤0.01% 2039
2025
Q2 		$14.3K Buy
624
+268
+75% +$6.65K ﹤0.01% 1708
2025
Q1 		$10.3K Buy
356
+135
+61% +$4.31K ﹤0.01% 1714
2024
Q4 		$8.21K Sell
221
-47
-18% -$2.15K ﹤0.01% 1514
2024
Q3 		$13K Hold
268
– – ﹤0.01% 966
2024
Q2 		$10.7K Hold
268
– – ﹤0.01% 956
2024
Q1 		$11.8K Hold
268
– – ﹤0.01% 711
2023
Q4 		$16.6K Sell
268
-98
-27% -$5.15K ﹤0.01% 557
2023
Q3 		$16.8K Sell
366
-60
-14% -$3.27K 0.01% 538
2023
Q2 		$24.5K Sell
426
-30
-7% -$1.33K 0.01% 441
2023
Q1 		$17.1K Sell
456
-18
-4% -$590 0.01% 539
2022
Q4 		$13.3K Hold
474
– – ﹤0.01% 591
2022
Q3 		$13K Sell
474
-1
-0.2% -$33 0.01% 558
2022
Q2 		$17K Sell
475
-41
-8% -$1.46K 0.01% 469
2022
Q1 		$19K Sell
516
-48
-9% -$1.36K 0.01% 476
2021
Q4 		$13K Buy
564
+61
+12% +$1.25K ﹤0.01% 629
2021
Q3 		$10K Sell
503
-46
-8% -$901 ﹤0.01% 686
2021
Q2 		$11K Buy
549
+76
+16% +$1.43K ﹤0.01% 671
2021
Q1 		$9K Hold
473
– – ﹤0.01% 805
2020
Q4 		$9K Hold
473
– – ﹤0.01% 743
2020
Q3 		$8K Hold
473
– – ﹤0.01% 718
2020
Q2 		$10K Buy
473
+10
+2% +$183 ﹤0.01% 614
2020
Q1 		$6K Buy
+463
New +$8.06K ﹤0.01% 692
2019
Q1 		– Sell
-22
Closed – – 1543
2018
Q4 		$0 Buy
22
+10
+83% +$197 ﹤0.01% 1461
2018
Q3 		$0 Sell
12
-3
-20% -$53 ﹤0.01% 1506
2018
Q2 		$0 Hold
15
– – ﹤0.01% 1496
2018
Q1 		$0 Sell
15
-28
-65% -$526 ﹤0.01% 1474
2017
Q4 		$0 Hold
43
– – ﹤0.01% 1517
2017
Q3 		$0 Sell
43
-187
-81% -$3.08K ﹤0.01% 1433
2017
Q2 		$4K Buy
+230
New +$3.65K ﹤0.01% 1084

Other funds holding AMPH

LG
LAM Group Lake Oswego, Oregon $201M AUM 22.35% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
SWP
Significant Wealth Partners Cary, Illinois $92.4M AUM 9.22% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.46B AUM 21.89% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
1IA
1620 Investment Advisors Plymouth, Massachusetts $161M AUM 30.15% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Versant Capital Management's AMPH Position: Q2 2026 in Review

Versant Capital Management held its Amphastar Pharmaceuticals (AMPH) position steady in Q2 2026 at 218 shares worth $4.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2453.

Versant Capital Management first reported a position in AMPH in Q2 2017 and has held it in 33 quarters since. The position peaked at $24.5K in Q2 2023. 20 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Versant Capital Management held 218 shares of Amphastar Pharmaceuticals worth $4.4K as of Q2 2026.
  • Versant Capital Management left its Amphastar Pharmaceuticals share count unchanged in Q2 2026.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2453 holding.
  • Versant Capital Management first reported a position in Amphastar Pharmaceuticals in Q2 2017 and has held it in 33 quarters since.
  • Versant Capital Management's Amphastar Pharmaceuticals position peaked at $24.5K in Q2 2023.
  • 20 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.